Story Poster

Georgia Bulldog WR George Pickens Makes Decision On Future

January 14, 2022

DON’T MISS OUT: Get our insider newsletter today!

ATHENS - One of Georgia’s top offensive playmakers, wide receiver George Pickens, has made his decision to skip his senior season and enter his name into the 2022 NFL Draft, according to his personal Instagram page.

Pickens came to Georgia as a consensus five-star wide receiver from Hoover High School in Alabama who chose the Bulldogs over Auburn on Signing Day of February 2019. He ended his career with a massive 51-yard reception in the first half of Georgia’s 33-18 win over No. 1 Alabama in the College Football Playoff National Championship Game in Indianapolis. 

A n instant impact player from day one, Pickens is a 6-foot-3 200-pound receiver with big-play ability who was a deep-threat option from the very beginning. He quickly turned into one of the top receivers in college football and has a very bright future in the NFL due to his size, ball skills, and ability to create separation.

Pickens was ranked as the No. 4 WR prospect in the country and the No. 24 overall prospect in the country for the 2019 class.

As a freshman in 2019, Pickens Coaches’ Freshman All-SEC Team with 49 catches for 727 yards and 8 touchdowns, each leading the team.

As a sophomore in 2020, The Hoover standout was consistent all season, catching 36 passes for 513 yards and a team-high six touchdowns.

As a junior this past fall, Pickens missed most of the team from a torn ACL that he suffered in March, but came back towards the end of the year, playing in the team’s final three games against Georgia Tech, Michigan and Alabama. Pickens would end the season with four receptions and two big catches against Alabama and Michigan.


Now you can own this commemorative keep-sake hardcover book to remember the season. DAWGSTRUCTION will be shipped in late February. The cover is subject to change. 

subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.